These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25739189)

  • 1. [Using deltalicin for the treatment of patients with diabetic retinopathy].
    Kresiun NV; Godlevskiĭ LS
    Eksp Klin Farmakol; 2014; 77(12):22-5. PubMed ID: 25739189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of deltalycyn and transcranial cerebellar stimulation upon recovery of retina after photo stress in patients with diabetic retinopathy.
    Kresyun NV
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1068-73. PubMed ID: 25581971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy.
    Parisi V; Uccioli L; Monticone G; Parisi L; Menzinger G; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 1994 Apr; 232(4):193-8. PubMed ID: 8034206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats.
    Bíró K; Pálhalmi J; Tóth AJ; Kukorelli T; Juhász G
    Neuroreport; 1998 Jun; 9(9):2029-33. PubMed ID: 9674588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary color P-VEP in diabetic retinopathy].
    Yan M; Yin SY
    Zhonghua Yan Ke Za Zhi; 1991 Jul; 27(4):200-3. PubMed ID: 1935442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy.
    Corduneanu A; Chişca V; Ciobanu N; Groppa S
    Rom J Ophthalmol; 2019; 63(4):367-371. PubMed ID: 31915735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I.
    Karlica D; Galetović D; Ivanisević M; Skrabić V; Znaor L; Jurisić D
    Coll Antropol; 2010 Jun; 34(2):525-9. PubMed ID: 20698126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability and repeatability of a photostress recovery test device, the macular degeneration detector (MDD-2), for diabetes and diabetic retinopathy assessment.
    Loughman J; Ratzlaff M; Foerg B; Connell P
    Retina; 2014 May; 34(5):1006-13. PubMed ID: 24136407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the metabolic control on latency values of visual evoked potentials (VEP) in patients with diabetes mellitus type 1.
    Matanovic D; Popovic S; Parapid B; Petronic I; Cirovic D; Nikolic D
    Arch Ital Biol; 2012 Dec; 150(4):251-8. PubMed ID: 23479458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delta-sleep inducing peptide and the drug deltaran: possible approaches to antistress protection].
    Koplik EV; Umriukhin PE; Konorova IL; Terekhina OL; Mikhaleva II; Gannushkina IV; Sudakov KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):50-4. PubMed ID: 18427460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological evaluation of the macular cone adaptation: VEP after photostress. A review.
    Parisi V
    Doc Ophthalmol; 2001 May; 102(3):251-62. PubMed ID: 11556488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The picture of visual evoked potentials in type 1 diabetes mellitus].
    Szabela DA; Loba J; Pałenga-Pydyn D; Tybor K; Ruxer J; Split W
    Klin Oczna; 2005; 107(7-9):492-7. PubMed ID: 16417005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram.
    Palmowski AM; Sutter EE; Bearse MA; Fung W
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2586-96. PubMed ID: 9375578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular recovery recorded by nyctometry in insulin-dependent diabetes mellitus.
    Frost-Larsen K
    Acta Ophthalmol Suppl (1985); 1991; (203):1-39. PubMed ID: 1667959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual electrophysiological responses in persons with type 1 diabetes.
    Parisi V; Uccioli L
    Diabetes Metab Res Rev; 2001; 17(1):12-8. PubMed ID: 11241887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes mellitus in elderly: geroprotective and antidiabetic properties of delta-sleep induced peptide].
    Odin VI; Belikova TV; Pushkova ES; Barr NA
    Adv Gerontol; 2004; 15():101-14. PubMed ID: 15754961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The picture of visual evoked potentials in type 2 diabetes mellitus].
    Szabela DA; Loba J; Pałenga-Pydyn D; Tybor K; Ruxer J; Split W
    Klin Oczna; 2005; 107(7-9):498-501. PubMed ID: 16417006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of flickering light on the retinal vessels in diabetic patients.
    Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA
    Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.